History and introduction of dendrimers

Abstract A dendrimer is one of the nanotechnology-based novel drug delivery systems that has attracted the attention of numerous researchers in the field of drug delivery. These three-dimensional nano-engineered polymeric structures provide uniform size and options for surface functionalization to develop an attractive tool for biomedical application. Hydrophobic as well as hydrophilic components including genetic and imaging materials could be delivered using this platform. The application of this delivery system has now been extended against several diseases in order to circumvent the limitations of conventional deliveries. Thus, this chapter is focused to provide the history of dendrimer development with different types, synthesis, properties, and application of dendrimer in the biomedical field.

[1]  P. Sengupta,et al.  Targeted drug delivery to the brain via intranasal nanoemulsion: Available proof of concept and existing challenges. , 2019, International journal of pharmaceutics.

[2]  J. Reymond,et al.  Peptide dendrimers as artificial enzymes, receptors, and drug-delivery agents. , 2006, Accounts of chemical research.

[3]  P. Kesharwani,et al.  Recent advances in folic acid engineered nanocarriers for treatment of breast cancer , 2020 .

[4]  C. Hawker,et al.  Unimolecular micelles and globular amphiphiles: dendritic macromolecules as novel recyclable solubilization agents , 1993 .

[5]  M. Hawthorne,et al.  Dendritic closomers: novel spherical hybrid dendrimers. , 2013, Chemical communications.

[6]  V. Percec,et al.  Rational Design of the First Nonspherical Dendrimer Which Displays Calamitic Nematic and Smectic Thermotropic Liquid Crystalline Phases , 1995 .

[7]  J. Tam,et al.  Synthesis of Peptide Dendrimer , 1994 .

[8]  Manisha Pandey,et al.  Dendrimers as Effective Carriers for the Treatment of Brain Tumor , 2018 .

[9]  P. Mehta,et al.  Dendrimers for pulmonary delivery: current perspectives and future challenges , 2019, New Journal of Chemistry.

[10]  Anil K Patri,et al.  Dendritic polymer macromolecular carriers for drug delivery. , 2002, Current opinion in chemical biology.

[11]  P. Kesharwani,et al.  GENERATION DEPENDENT TARGETING POTENTIAL OF DONEPEZIL LOADED POLY (PROPYLENEIMINE) DENDRIMER THROUGH GOAT NASAL MUCOSA , 2018, International Journal of Pharmacy and Pharmaceutical Sciences.

[12]  J Fraser Stoddart,et al.  Design and synthesis of glycodendrimers. , 2002, Journal of biotechnology.

[13]  T. Tsumuraya,et al.  General strategy for the systematic synthesis of oligosiloxanes. Silicone dendrimers , 1990 .

[14]  P. Kesharwani,et al.  The potential of dendrimer in delivery of therapeutics for dentistry , 2019, Heliyon.

[15]  Walter H Backes,et al.  Evaluation of Gd(III)DTPA‐terminated poly(propylene imine) dendrimers as contrast agents for MR imaging , 2006, NMR in biomedicine.

[16]  V. Mishra,et al.  Dendrimer technologies for brain tumor. , 2016, Drug discovery today.

[17]  P. Kesharwani,et al.  Effect of surface capping on targeting potential of folate decorated poly (propylene imine) dendrimers , 2015, Drug development and industrial pharmacy.

[18]  R. Mülhaupt,et al.  Dendritic polyols based on carbosilanes ‐ lipophilic dendrimers with hydrophilic skin , 1996 .

[19]  N. K. Jain,et al.  Formulation development and in vitro-in vivo assessment of the fourth-generation PPI dendrimer as a cancer-targeting vector. , 2014, Nanomedicine.

[20]  Umesh Gupta,et al.  Dendrimers as an Effective Nanocarrier in Cardiovascular Disease. , 2015, Current pharmaceutical design.

[21]  Fengli Gao,et al.  Folic acid-modified diatrizoic acid-linked dendrimer-entrapped gold nanoparticles enable targeted CT imaging of human cervical cancer , 2018, Journal of Cancer.

[22]  R. Tekade,et al.  Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy. , 2017, Drug discovery today.

[23]  M. Tempero,et al.  A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer , 2013, British Journal of Cancer.

[24]  Nathalie Launay,et al.  A General Synthetic Strategy for Neutral Phosphorus‐Containing Dendrimers , 1994 .

[25]  N. K. Jain,et al.  Generation dependent cancer targeting potential of poly(propyleneimine) dendrimer. , 2014, Biomaterials.

[26]  M A Fischl,et al.  Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  M. Malkoch,et al.  CHAPTER 1. Introduction to Dendrimers and Other Dendritic Polymers , 2020 .

[28]  Morteza Milani,et al.  Dendrimers: synthesis, applications, and properties , 2014, Nanoscale Research Letters.

[29]  Jeffrey S. Moore,et al.  Rapid Construction of Large‐size Phenylacetylene Dendrimers up to 12.5 Nanometers in Molecular Diameter , 1993 .

[30]  E. W. Meijer,et al.  Synthesis and Characterization of a Chiral Dendrimer Derived from Pentaerythritol , 1994 .

[31]  George R. Newkome,et al.  Micelles. Part 1. Cascade molecules: a new approach to micelles. A [27]-arborol , 1985 .

[32]  D. Luo,et al.  Poly(ethylene glycol)-Conjugated PAMAM Dendrimer for Biocompatible, High-Efficiency DNA Delivery , 2002 .

[33]  Nancy E. Magaña-Vergara,et al.  In vitro activity of steroidal dendrimers on Trypanosoma cruzi epimastigote form with PAMAM dendrons modified by "click" chemistry. , 2019, Bioorganic chemistry.

[34]  R. Tekade,et al.  The effect of polyethylene glycol spacer chain length on the tumor-targeting potential of folate-modified PPI dendrimers , 2013, Journal of Nanoparticle Research.

[35]  J. Fréchet,et al.  Discovery of dendrimers and dendritic polymers: A brief historical perspective* , 2002 .

[36]  P. Kesharwani,et al.  Conclusion and Future Prospective of Polymeric Nanoparticles for Cancer Therapy , 2019, Polymeric Nanoparticles as a Promising Tool for Anti-cancer Therapeutics.

[37]  P. Ellis,et al.  Nanoparticle albumin-bound paclitaxel for metastatic breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  Claudia Sandoval-Yáñez,et al.  Dendrimers: Amazing Platforms for Bioactive Molecule Delivery Systems , 2020, Materials.

[39]  David R. Liu,et al.  Sequence-Controlled Polymers , 2013, Science.

[40]  N. K. Jain,et al.  Lyophilized mucoadhesive-dendrimer enclosed matrix tablet for extended oral delivery of albendazole. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[41]  P. Kesharwani,et al.  Dendrimer toxicity: Let's meet the challenge. , 2010, International journal of pharmaceutics.

[42]  C. Hawker,et al.  Preparation of polymers with controlled molecular architecture. A new convergent approach to dendritic macromolecules , 1990 .

[43]  Viney Lather,et al.  Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues , 2014, Journal of pharmacy & bioallied sciences.

[44]  B. Nanjwade,et al.  Dendrimers: emerging polymers for drug-delivery systems. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[45]  F. Sarkar,et al.  Solubility enhancement and targeted delivery of a potent anticancer flavonoid analogue to cancer cells using ligand decorated dendrimer nano-architectures. , 2016, Journal of colloid and interface science.

[46]  P. Kesharwani,et al.  Synthesis, characterization and in vitro assessment of colloidal gold nanoparticles of Gemcitabine with natural polysaccharides for treatment of breast cancer , 2020 .

[47]  Yuanjie Liu,et al.  Dual-functionalized PAMAM dendrimers with improved P-glycoprotein inhibition and tight junction modulating effect. , 2013, Biomacromolecules.

[48]  Sanjeev Banerjee,et al.  Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 overexpressing pancreatic cancer cells. , 2015, Colloids and surfaces. B, Biointerfaces.

[49]  M. Cloninger,et al.  Mannose functionalization of a sixth generation dendrimer. , 2001, Biomacromolecules.

[50]  N. K. Jain,et al.  Cancer targeting potential of some ligand-anchored poly(propylene imine) dendrimers: a comparison. , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[51]  Muktika Tekade,et al.  The use of nanoscaffolds and dendrimers in tissue engineering. , 2017, Drug discovery today.

[52]  Sheo Datta Maurya,et al.  POTENTIAL APPLICATION OF DENDRIMERS IN DRUG DELIVERY: A CONCISE REVIEW AND UPDATE , 2016 .

[53]  Prashant Kesharwani,et al.  Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery. , 2015, Drug discovery today.

[54]  T. Xu,et al.  Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery. , 2008, Frontiers in bioscience : a journal and virtual library.

[55]  Jong-sang Park,et al.  Synthesis of a Barbell-like Triblock Copolymer, Poly(l-lysine) Dendrimer-block-Poly(ethylene glycol)-block-Poly(l-lysine) Dendrimer, and Its Self-Assembly with Plasmid DNA , 2000 .

[56]  Manisha Pandey,et al.  Nose to brain delivery of nanocarriers towards attenuation of demented condition. , 2020, Current pharmaceutical design.

[57]  S Sridevi,et al.  Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[58]  N. K. Jain,et al.  A review on comparative study of PPI and PAMAM dendrimers , 2016, Journal of Nanoparticle Research.

[59]  J. F. Stoddart,et al.  Synthesis of Carbohydrate-Containing Dendrimers. 5. Preparation of Dendrimers Using Unprotected Carbohydrates , 1997 .

[60]  L. Brannon-Peppas,et al.  Nanoparticle and targeted systems for cancer therapy. , 2004, Advanced drug delivery reviews.

[61]  Francis C Szoka,et al.  Designing dendrimers for biological applications , 2005, Nature Biotechnology.

[62]  Ryan M. Pearson,et al.  Dendron‐Based Micelles for Topical Delivery of Endoxifen: A Potential Chemo‐Preventive Medicine for Breast Cancer , 2014 .

[63]  Xue Li,et al.  Stimuli-responsive polymers and their applications , 2017 .

[64]  D. Tomalia,et al.  CHARACTERIZATIONS OF CORE-SHELL TECTO-(DENDRIMER) MOLECULES BY TAPPING MODE ATOMIC FORCE MICROSCOPY , 1999 .

[65]  Martin W. Brechbiel,et al.  Metal-chelate-dendrimer-antibody constructs for use in radioimmunotherapy and imaging , 1994 .

[66]  Michael B. Hall,et al.  Dendritic macromolecules: synthesis of starburst dendrimers , 1986 .

[67]  J. Frolík,et al.  Biocompatible Size-Defined Dendrimer-Albumin Binding Protein Hybrid Materials as a Versatile Platform for Biomedical Applications. , 2016, Macromolecular bioscience.

[68]  N. K. Jain,et al.  Mucoadhesion: A promising approach in drug delivery system , 2016 .

[69]  P. Kesharwani,et al.  In Vitro and In Vivo Skin Distribution of 5α-Reductase Inhibitors Loaded Into Liquid Crystalline Nanoparticles. , 2017, Journal of pharmaceutical sciences.

[70]  Murray Goodman,et al.  Collagen mimetic dendrimers. , 2002, Journal of the American Chemical Society.

[71]  Paul J. Flory,et al.  Molecular Size Distribution in Three Dimensional Polymers. I. Gelation1 , 1941 .

[72]  Shuhua Bai,et al.  Dendrimers as a carrier for pulmonary delivery of enoxaparin, a low-molecular weight heparin. , 2007, Journal of pharmaceutical sciences.

[73]  P. Kesharwani,et al.  Entrapment of drug-sorbate complex in submicron emulsion: A potential approach to improve antimicrobial activity in bacterial corneal infection , 2019, Journal of Drug Delivery Science and Technology.

[74]  N. K. Jain,et al.  Ligand anchored poly(propyleneimine) dendrimers for brain targeting: Comparative in vitro and in vivo assessment. , 2016, Journal of colloid and interface science.

[75]  R. Roy,et al.  Glycodendrimers: novel glycotope isosteres unmasking sugar coding. case study with T-antigen markers from breast cancer MUC1 glycoprotein. , 2002, Journal of biotechnology.

[76]  Michael Hawkins,et al.  Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[77]  P. Kesharwani,et al.  Current attempts to implement microRNA-based diagnostics and therapy in cardiovascular and metabolic disease: a promising future. , 2017, Drug discovery today.

[78]  P. Sengupta,et al.  Pharmacokinetic and Pharmacodynamic Features of Nanoemulsion Following Oral, Intravenous, Topical and Nasal Route. , 2017, Current pharmaceutical design.

[79]  P. Kesharwani,et al.  Theranostic application of nanoemulsion in chemotherapy. , 2020, Drug discovery today.

[80]  G. Mishra,et al.  Polymeric Nanocarriers: A New Horizon for the Effective Management of Breast Cancer. , 2018, Current pharmaceutical design.

[81]  N. K. Jain,et al.  Generation dependent hemolytic profile of folate engineered poly(propyleneimine) dendrimer , 2015 .

[82]  P. Kesharwani,et al.  Dendrimer-Based Nanoparticulate Delivery System for Cancer Therapy , 2019, Polymeric Nanoparticles as a Promising Tool for Anti-cancer Therapeutics.

[83]  Michael Malkoch,et al.  Simplifying the synthesis of dendrimers: accelerated approaches. , 2012, Chemical Society reviews.

[84]  Sanjeev Banerjee,et al.  PAMAM dendrimers as promising nanocarriers for RNAi therapeutics , 2015 .

[85]  R. Tekade,et al.  Impact of pegylation on biopharmaceutical properties of dendrimers , 2015 .

[86]  P. Kesharwani,et al.  PEGylated PAMAM dendrimers: Enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery. , 2016, Acta biomaterialia.

[87]  J. Tam,et al.  Peptide dendrimers: applications and synthesis. , 2002, Journal of biotechnology.

[88]  P. Kesharwani,et al.  Investigation on Secondary Structure Alterations of Protein Drugs as an Indicator of Their Biological Activity Upon Thermal Exposure , 2019, The Protein Journal.

[89]  J. Fréchet,et al.  Synthesis and Surface Functionalization of Aliphatic Polyether Dendrons , 2000 .

[90]  R. Roy,et al.  Solid-phase synthesis of dendritic sialoside inhibitors of influenza A virus haemagglutinin , 1993 .

[91]  Keerti Jain,et al.  Dendrimer as nanocarrier for drug delivery , 2014 .

[92]  T. Xu,et al.  Dendrimers as drug carriers: applications in different routes of drug administration. , 2008, Journal of pharmaceutical sciences.

[93]  E. W. Meijer,et al.  New Dendrimer–Peptide Host–Guest Complexes: Towards Dendrimers as Peptide Carriers , 2002, Chembiochem : a European journal of chemical biology.

[94]  T. Vandamme,et al.  Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[95]  V. Mishra,et al.  Dendrimer-mediated approaches for the treatment of brain tumor , 2016, Journal of biomaterials science. Polymer edition.

[96]  James R. Dewald,et al.  A New Class of Polymers: Starburst-Dendritic Macromolecules , 1985 .

[97]  Z. Sideratou,et al.  Solubilization and Release Properties of PEGylated Diaminobutane Poly(propylene imine) Dendrimers , 2001 .

[98]  R. Mülhaupt,et al.  A mesogen‐functionized carbosilane dendrimer: A dendritic liquid crystalline polymer , 1996 .

[99]  A. Ray,et al.  Poly(amido amine) dendrimers as absorption enhancers for oral delivery of camptothecin. , 2013, International journal of pharmaceutics.

[100]  N. K. Jain,et al.  Evaluation of dendrimer safety and efficacy through cell line studies. , 2011, Current drug targets.

[101]  P. Kesharwani,et al.  Curcumin loaded poly (amidoamine) dendrimer-plamitic acid core-shell nanoparticles as anti-stress therapeutics , 2020, Drug development and industrial pharmacy.

[102]  J. Schellens,et al.  Oral Delivery of Taxanes , 2001, Investigational New Drugs.

[103]  M. Piccart,et al.  A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC). , 2014 .

[104]  N. K. Jain,et al.  A review of nanocarriers for the delivery of small interfering RNA. , 2012, Biomaterials.

[105]  D. Reinhoudt,et al.  Controlled assembly of nanosized metallodendrimers , 1996 .

[106]  Andrew C Larson,et al.  Multifunctional dendrimer-based nanoparticles for in vivo MR/CT dual-modal molecular imaging of breast cancer , 2013, International journal of nanomedicine.

[107]  T. Pal,et al.  A novel approach for nanoemulsion components screening and nanoemulsion assay of olmesartan medoxomil through a developed and validated HPLC method , 2013 .

[108]  P. Kesharwani,et al.  Polyvalent Folate-Dendrimer-Coated Iron Oxide Theranostic Nanoparticles for Simultaneous Magnetic Resonance Imaging and Precise Cancer Cell Targeting. , 2017, Biomacromolecules.

[109]  Roberto Parise-Filho,et al.  Dendrimers in the context of nanomedicine. , 2019, International journal of pharmaceutics.

[110]  P. Kesharwani,et al.  Dendrimer entrapped microsponge gel of dithranol for effective topical treatment , 2019, Heliyon.

[111]  A. D'emanuele,et al.  In vitro evaluation of dendrimer prodrugs for oral drug delivery. , 2007, International journal of pharmaceutics.

[112]  C. Kokare,et al.  Intranasal teriflunomide microemulsion: An improved chemotherapeutic approach in glioblastoma , 2019, Journal of Drug Delivery Science and Technology.

[113]  E. Buhleier,et al.  "Cascade"- and "Nonskid-Chain-like" Syntheses of Molecular Cavity Topologies , 1978 .

[114]  N. K. Jain,et al.  Generation Dependent Safety and Efficacy of Folic Acid Conjugated Dendrimer Based Anticancer Drug Formulations , 2014, Pharmaceutical Research.

[115]  T. P. Davis,et al.  Understanding Effects of PAMAM Dendrimer Size and Surface Chemistry on Serum Protein Binding with Discrete Molecular Dynamics Simulations. , 2018, ACS sustainable chemistry & engineering.

[116]  F. Alustiza,et al.  Formation of dendrimer-guest complexes as a strategy to increase the solubility of a phenazine N, N′-dioxide derivative with antitumor activity , 2019, Heliyon.

[117]  Ling Peng,et al.  Poly(amidoamine) dendrimers: covalent and supramolecular synthesis , 2019, Materials Today Chemistry.

[118]  Manisha Pandey,et al.  Dendrimer-Based Nanocarriers in Lung Cancer Therapy , 2019, Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer.

[119]  Neil B. McKeown,et al.  Engineering of Dendrimer Surfaces to Enhance Transepithelial Transport and Reduce Cytotoxicity , 2003, Pharmaceutical Research.

[120]  A. Salgado,et al.  Dendrimers and derivatives as a potential therapeutic tool in regenerative medicine strategies—A review , 2010 .

[121]  Antony D'Emanuele,et al.  The use of a dendrimer-propranolol prodrug to bypass efflux transporters and enhance oral bioavailability. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[122]  P C Lauterbur,et al.  Dendrimer‐based metal chelates: A new class of magnetic resonance imaging contrast agents , 1994, Magnetic resonance in medicine.

[123]  D. Seebach,et al.  A Simple Procedure for the Preparation of Chiral ‘Tris(hydroxymethyl)methane’ Derivatives , 1993 .

[124]  N. K. Jain,et al.  Dendrimer generational nomenclature: the need to harmonize. , 2015, Drug discovery today.

[125]  K. Dua,et al.  Recent Advances in Oncological Submissions of Dendrimer. , 2017, Current pharmaceutical design.

[126]  Seungpyo Hong,et al.  Dendrimer-based nanocarriers: a versatile platform for drug delivery. , 2017, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[127]  Manisha Pandey,et al.  Nanotechnology based approaches for anti-diabetic drugs delivery. , 2018, Diabetes research and clinical practice.

[128]  N. K. Jain,et al.  One platform comparison of solubilization potential of dendrimer with some solubilizing agents , 2015, Drug development and industrial pharmacy.

[129]  Donald A. Tomalia,et al.  Dendrimers with Hydrophobic Cores and the Formation of Supramolecular Dendrimer−Surfactant Assemblies , 1997 .

[130]  M. Morilla,et al.  Increased brain radioactivity by intranasal 32P-labeled siRNA dendriplexes within in situ-forming mucoadhesive gels , 2012, International journal of nanomedicine.

[131]  Keerti Jain,et al.  Dendrimer nanohybrid carrier systems: an expanding horizon for targeted drug and gene delivery. , 2017, Drug discovery today.

[132]  Donald A Tomalia,et al.  Dendrimers in biomedical applications--reflections on the field. , 2005, Advanced drug delivery reviews.

[133]  Umesh Gupta,et al.  Dendrimer nanoarchitectures for cancer diagnosis and anticancer drug delivery. , 2017, Drug discovery today.

[134]  Marta Sowinska,et al.  Advances in the chemistry of dendrimers , 2014 .

[135]  Neil M. Stainton,et al.  A convergent synthesis of extended aryl ester dendrimers , 1994 .

[136]  I. Vural,et al.  In Vitro/In Vivo Evaluation of Dexamethasone--PAMAM Dendrimer Complexes for Retinal Drug Delivery. , 2015, Journal of pharmaceutical sciences.

[137]  P. Kesharwani,et al.  Dendrimers in Targeting and Delivery of Drugs , 2017 .

[138]  P. Kesharwani,et al.  Immune checkpoint inhibitors: a promising anticancer therapy. , 2019, Drug discovery today.

[139]  D. Farin,et al.  Surface Fractality of Dendrimers , 1991 .

[140]  Omathanu Perumal,et al.  Effect of poly(amidoamine) (PAMAM) dendrimer on skin permeation of 5-fluorouracil. , 2008, International journal of pharmaceutics.

[141]  F. Szoka,et al.  Polyester dendritic systems for drug delivery applications: design, synthesis, and characterization. , 2002, Bioconjugate chemistry.

[142]  Deborah S. Goldberg,et al.  G3.5 PAMAM dendrimers enhance transepithelial transport of SN38 while minimizing gastrointestinal toxicity. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[143]  Manisha Pandey,et al.  Dendrimer-entrapped gold nanoparticles as promising nanocarriers for anticancer therapeutics and imaging , 2019, Progress in Materials Science.

[144]  Keerti Jain,et al.  A review of glycosylated carriers for drug delivery. , 2012, Biomaterials.

[145]  Manisha Pandey,et al.  Nanoemulsions as Effective Carriers for the Treatment of Lung Cancer , 2019, Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer.

[146]  N. K. Jain,et al.  Surface-engineered dendrimers for dual drug delivery: A receptor up-regulation and enhanced cancer targeting strategy , 2008, Journal of drug targeting.